Healthcare · Pharmaceuticals & Biotechnology
QVM read Momentum-led Quality Moderate, Valuation Expensive, Momentum Bullish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #62 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 16 Mar 2026 | P. Manideep | Other | Sell | 0 | ₹0 |
| 28 Feb 2026 | G. Suresh Kumar | Director | Sell | 0 | ₹0 |
| 28 Feb 2026 | P. Srinivasa Rao | Employee / designated person | Sell | 0 | ₹0 |
| 28 Feb 2026 | P. Srinivasa Rao | Employee / designated person | Sell | 0 | ₹0 |
| 24 Feb 2026 | G. Suresh Kumar | Director | Sell | 0 | ₹0 |
| 19 Feb 2026 | G. Suresh Kumar | Director | Sell | 0 | ₹0 |
| 28 Nov 2025 | G. Suresh Kumar | Director | Sell | 0 | ₹0 |
| 5 Nov 2025 | Hima Bindu Potluri | Promoter | Pledge | 0 | ₹125.58 Cr |
| 11 Sep 2025 | Vamsi Krishna Potluri | Promoter group | Buy | 0 | ₹0 |
| 11 Sep 2025 | Trilok Potluri | Promoter group | Buy | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 11 Sep 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | Buy | 546,684 | 454.3400 | NSE |
| 11 Sep 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | Sell | 546,684 | 454.4500 | NSE |
| 6 Mar 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 544,383 | 184.8600 | NSE |
| 6 Mar 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 544,383 | 184.8500 | NSE |
| 4 Mar 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 517,107 | 164.2000 | NSE |
| 4 Mar 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 517,107 | 163.9700 | NSE |
| 31 Dec 2020 | VEERAVENKATA SATYANARAYANA MURTHY TALLURI | Bulk | Sell | 661,180 | 115.1000 | NSE |
| 31 Dec 2020 | POTLURI INFRA PROJECTS LLP | Bulk | Buy | 661,180 | 115.1000 | NSE |
| 8 Dec 2020 | RAMESH BABU POTLURI | Block | Buy | 1,468,100 | 94.7000 | NSE |
| 8 Dec 2020 | HIMA BINDU POTLURI | Block | Buy | 1,390,480 | 94.7000 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| — | Final Dividend - Rs. - 0.4000 | — | — |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 1 Aug 2026 | Financial Results/Other business matters | Yes |
| 31 Jul 2026 | Financial Results/Other business matters | Yes |
| 22 May 2026 | Financial Results/Dividend/Other business matters | Yes |
| 7 Feb 2026 | Financial Results/Other business matters | Yes |
| 8 Nov 2025 | Financial Results/Other business matters | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 30 Sep 2026 | AGM/EGM | SMS Pharmaceuticals Ltd - 532815 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| 29 Sep 2026 | AGM/EGM | SMS Pharmaceuticals Ltd - 532815 - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| 10 Sep 2026 | Company Update | SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 5 Sep 2026 | Company Update | SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 4 Sep 2026 | AGM/EGM | SMS Pharmaceuticals Ltd - 532815 - Notice Of 38Th Annual General Meeting To Be Held On 29Th September, 2026 |
| 4 Sep 2026 | Others | SMS Pharmaceuticals Ltd - 532815 - Business Responsibility and Sustainability Reporting (BRSR) |
| 4 Sep 2026 | Others | SMS Pharmaceuticals Ltd - 532815 - Reg. 34 (1) Annual Report. |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
